ReviewCurrent opinion in nephrology and hypertension2015
Body composition in chronic kidney disease.
Review in Current opinion in nephrology and hypertension, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 98 citations in OpenAlex.
- Curcumin Supplementation (MerivaNutrients · 2022Trial
- Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients.Journal of cachexia, sarcopenia and muscle · 2019Trial
- Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease.Pediatric nephrology (Berlin, Germany) · 2018Trial
- Comment on Toki et al. Seasonal BMI Amplitude and Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82).Diabetes care · 2026Article
- Mechanisms of Obesity-Related Kidney Disease: From Adipose Depot Biology to the Chymase-Aldosterone and Ghrelin-Leptin Axes.Biomolecules · 2026Review
- The Role of Precision Nutrition in Kidney Disease.Clinical journal of the American Society of Nephrology : CJASN · 2026Review
- Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026Observational
- Association of different types of physical activity with sarcopenia and its parameters in peritoneal dialysis patients: an isotemporal substitution analysis.Frontiers in nutrition · 2026Article
- Practical Guide to Nutritional Assessment in CKD: Current Tools, Emerging Technologies, and Future Directions.Clinical journal of the American Society of Nephrology : CJASN · 2025Review
- Association of Phase Angle with Body Composition in Hemodialysis Patients: A Case-Control Study.Life (Basel, Switzerland) · 2025Article
- Cut-Off Values for Sarcopenia and Mortality Risk in Older Dialysis Patients.Journal of clinical practice and research · 2025Article
- Comparison of hemodialysis urea clearance using spent dialysate and Kt/Vurea equations.Artificial organs · 2025Article
- Article
- Association between uric acid to high-density lipoprotein cholesterol ratio and chronic kidney disease in Chinese patients with type 2 diabetes mellitus: a cross-sectional study.Frontiers in nutrition · 2025Article
- The expected changes with different periods of home-based resistance exercise in patients with chronic kidney disease.Journal of the Chinese Medical Association : JCMA · 2024Observational
- The Effect of Intradialytic Exercise Using Virtual Reality on the Body Composition of Patients with Chronic Kidney Disease.Nutrients · 2024Article
- Subclinical Hypothyroidism in Patients with Obesity and Metabolic Syndrome: A Narrative Review.Nutrients · 2023Review
- Review
- Article
- Association of sarcopenia and its components with clinical outcomes in patients undergoing peritoneal dialysis.Kidney research and clinical practice · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
purpose of reviewTo summarize the latest information on body composition among patients with chronic kidney disease and its association with outcomes. RECENT
findingsObesity is increasing among patients with end-stage renal disease and is more prevalent when direct measures of adiposity are used rather than BMI. High BMI is not associated with better survival among patients with earlier chronic kidney disease or after kidney transplantation, suggesting that excess fat is most protective among the sickest patients. Despite the positive association between BMI and survival among patients with end-stage renal disease, visceral fat is associated with coronary artery calcification and adverse cardiovascular events. Muscle wasting is prominent among patients with chronic kidney disease, sometimes even in the setting of obesity. Obesity and muscle wasting are associated with worse physical functioning. Indicators of low muscle size and strength are associated with higher mortality. Some interventions can affect body composition, but whether they affect survival has not been determined. SUMMARY: Recent studies show that a high BMI is not protective for all patients with chronic kidney disease and is associated with poor physical functioning and frailty. Visceral adiposity is associated with adverse cardiovascular outcomes. Sarcopenia is common among patients with end-stage renal disease and is associated with worse physical performance and higher mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.